Medical advancements like the X-ray, CT scan, MRI and ultrasound changed medicine forever, allowing doctors to peek inside the human body. But until now, there hasn’t been a reliable way to monitor tissue as it heals after surgeries with many patients suffering life-threatening complications. Gastrointestinal surgeries, in particular, see up to 10% of patients develop severe complications with up to 40% of those proving fatal.
Exero Medical is changing that with xBar, a temporary tissue sensor implanted right at the surgical site. The xBar diagnostic system collects data and alerts medical providers to trouble early — saving lives, avoiding follow-up surgeries and shortening hospital stays. A study on xBar’s effectiveness found the technology reliably detected anastomotic leaks at least three days earlier than the current standard of care.
The technology has been granted the U.S. Food and Drug Administration’s Breakthrough Designation for medical devices that provide more effective treatment or diagnosis of potentially life-threatening or irreversible conditions or diseases.
Authority Magazine – Health Tech: Dr Erez Shor on How Exero Medical’s Technology Can Make an Important Impact on Our Overall Wellness
BioWorld – Exero Starts First-in-Human Trial of Wireless, Biodegradable GI Surgical Sensor
Coruzant Technologies – Deduce Healing with New Scientific Breakthroughs in Diagnostics
HospiMedica – Post-Surgery Tissue Monitoring and Diagnostic System Detects Anastomotic Leaks after GI Surgery
Journal of Surgical Research – Implantation of an Impedance Sensor for Early Detection of Gastrointestinal Anastomotic Leaks
Mass Device – Exero Medical Smart Sensor Gains FDA Breakthrough Nod
Medical Device Network – Exero Begins Subject Enrollment in Diagnostic System Trial
MedTech Strategist – Exero Medical: Detecting Surgical Complications Before They Turn Lethal
MEDX Xelerator – Exero Medical’s Multi-Center Study Demonstrates Early Detection of Anastomotic Leaks
NoCamels – Life-Saving Sensor Monitors Dangerous Fallout of Stomach Surgery
Surgical Robotics Technology – Exero Medical Appoints Dr. Deborah Nagle to its Scientific Advisory Board
The Digital Executive – Curiosity and Technology Started a Company and Solved a Medical Problem
The Times of Israel – In Clinical Trial, Sensor Implanted to Detect Dangerous Gastrointestinal Leaks
U.S. Food and Drug Administration – Breakthrough Designation
Every year, American entrepreneurs start more than half a million companies. More than 90% of them will fail, with only 200 ever passing $100 million in revenue. At Unorthodox Ventures, we know how to reach $300 million. Jump in with us.
